News
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary ... the company increased the installed capacity of Tablets and Capsules from 6750 million nos to 6950 million nos. They increased the ...
Learn more about whether Ionis Pharmaceuticals, Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's ...
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...
* Computed on last 15 days' trading figures.
British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...
GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.
Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth more ...
As per Vantage Market Research, the Pharmaceutical Manufacturing Market is poised for growth due to various factors, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results